Korea Moves to Garner More Roche Tamiflu, GSK Relenza Against Swine Flu

SEOUL - The South Korean government is moving quickly to garner more of Roche's Tamiflu (oseltamivir) and Biota's Relenza (zanamivir) in its prevention against the swine flu virus reported in Mexico, the U.S. and the UK